News for hackers. Stuff that matters.
Re:Patient Number One in a new cancer treatment by epistasis on Wednesday July 19, 2017 @04:43PM (#14807726)
Congratulations on a successful treatment! It is so wonderful to hear stories like these. Immuno-oncology is bringing great hope to mutation-rich cancers like melanoma.

>I'm certain that Big Pharma doesn't like these treatments.

You would be certainly wrong on that part. Immuno-oncology has been "Big Pharma's" major focus for the past 5-10 years, inspired in no small part by the work of Rosenburg and many others. One of the most recent approvals discussed on HN was for a CAR T-cell targeted against CD19. Big Pharma would also be very happy to sell immune checkpoint inhibitors for use in combination therapy with adoptive cell transfer.

Re:Patient Number One in a new cancer treatment by byteCoder on Wednesday July 19, 2017 @06:03PM (#14808406)
I hope that I'm wrong. Many more patients can possibly be saved with more widespread use of this treatment. Of course, the FDA needs to modernize their own approval processes to deal with such personalized treatments. It's my understanding that my lab-expanded lymphocytes needed to be individually approved by the FDA.

I do know that my specific trial at NIH was sponsored by Lion Biotechnologies as part of that company acquiring a license to reproduce the laboratory processing for the TIL ACT.

Re:Patient Number One in a new cancer treatment by jfarlow on Wednesday July 19, 2017 @06:49PM (#14808689)
Yep. Novartis' new CAR was recommended for approval last week. ~100 are in the FDA pipeline, and now that the first was unanimously approved, expect a lot more.

Paywalled, but a good review of the 100 in trials right now: https://www.ncbi.nlm.nih.gov/pubmed/27613725